TrialArthritis research & therapy2017

Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.

Karel Pavelka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.